Navigation Links
Pharma majors gear to supply anti-anthrax drug

The panic that has gripped the U.S with anthrax bacterial infections coming to light has led to an increased demand for the drug used in its treatment - Ciprofloxacin. Already there is news that the German pharma major Bayer is tripling its production of Ciprofloxacin to cater to the burgeoning demand and will supply 200 million tablets in the next three months. In fact, Bayer holds the U.S. patents on the most common forms of Ciprofloxacin and these expire on December 9, 2003. //

Ranbaxy Laboratories produces both the bulk and formulation forms of ciprofloxacin and according to a company spokesman, the U.S. Senator, Mr. Charles Schumer, has approached Ranbaxy's U.S. arm, Ranbaxy Laboratories Inc. regarding supply of Cipro in large numbers - Mr. Schumer had asked Ranbaxy for a supply of 20 million tablets a month of Ciprofloxacin for anthrax treatment starting December. The treatment for anthrax entails one ciprofloxacin twice a day and the U.S. Government wants to purchase enough Ciprofloxacin to cover 12 million patients for 60 days.

Ranbaxy is among the few Indian companies with the U.S. Food and Drug Administration(FDA) approval for the manufacture of Ciprofloxacin. The Mumbai-based Cipla, which is also approved by the U.S. FDA, has also offered to supply large quantities of Ciprofloxacin, the active ingredient of Cipro to a generic producer in the U.S.

Ciprofloxacin is a U.S. FDA wide spectrum antibiotic for the treatment of anthrax and belongs to the fluoroquinolone class of drugs which has a global market of $3.85 billion and is reportedly growing at 16 percent per annum. In India, Ciprofloxacin is the second largest molecule after Amoxycillin.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharma cos must forge Strategic alliances
4. Medicis Pharmaceutical company enters pediatric market
5. Pharmacies in for a dose of bitter medicine
6. Andhra Pradesh to set up Pharma City
7. Sun Pharma to launch chiral version of omeprazole soon
8. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
9. Pharmacia may take 51.5 percent Abbott stake
10. Pharmaceutical companies are targeting patients
11. FDA approves Watson Pharmaceuticals Oxytrol patch
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 07, 2020 , ... As part of their efforts to prioritize ... spring, The Bengtson Center team decided to temporarily suspend most in-person appointments, with the ... basis. With the offices now open again, the leading plastic surgeons in Michigan ...
(Date:8/5/2020)... LOS ANGELES (PRWEB) , ... August 05, 2020 ... ... most used Social Emotional Learning (SEL) program, has been named to the inaugural ... of School Librarians (AASL). , This recognition honors electronic resources that provide ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... of consciousness, seizures, prolonged length of hospital stay, or even death. A researcher ... insulin-treated patients with Type 2 diabetes to see if the use of continuous ...
(Date:8/5/2020)... (PRWEB) , ... August 05, 2020 , ... Today, ... , the leading trade and investment platform for Africa, announced that they have entered ... YPO Africa and Invest Africa to support each other in their African impact efforts, ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... Florida will launch its Suite360:Mental Health and Prevention program district-wide, developed to help ... Child Trafficking Prevention. , Florida schools and districts must provide their students ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... , ... Member Care Solutions announced a deal with American Family Care (AFC) ... of their cloud based membership management software platform. , “We are very pleased and ... the perfect match for many reasons, but AFC’s need to quickly set up, market, ...
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, ... to announce the addition of Moderna to its growing customer roster. , TrialScope ... technology for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... an extensive awareness campaign to let those who are experiencing abuse know that ... the services they need through the Miami-Dade County’s Coordinated Victim’s Assistance Center (CVAC) ...
Breaking Medicine Technology: